Indoco Remedies Limited (INDOCO.NS)
INR 337.35
(-0.41%)
INR 337.35
(-0.41%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 12.06 Billion INR | -27.83% |
| 2022 | 9.03 Billion INR | 10.01% |
| 2021 | 8.21 Billion INR | 17.05% |
| 2020 | 7.01 Billion INR | 0.7% |
| 2019 | 6.96 Billion INR | 10.78% |
| 2018 | 6.28 Billion INR | 4.43% |
| 2017 | 6.02 Billion INR | -2.13% |
| 2016 | 6.15 Billion INR | 18.66% |
| 2015 | 5.18 Billion INR | 18.64% |
| 2014 | 4.37 Billion INR | 18.08% |
| 2013 | 3.7 Billion INR | 23.92% |
| 2012 | 2.98 Billion INR | 39.08% |
| 2011 | 2.14 Billion INR | 4.08% |
| 2010 | 2.06 Billion INR | -36.9% |
| 2009 | 3.27 Billion INR | 58.28% |
| 2008 | 2.06 Billion INR | 0.0% |
| 2007 | - INR | -100.0% |
| 2006 | 2.53 Billion INR | 34.39% |
| 2005 | 1.88 Billion INR | 26.07% |
| 2004 | 1.49 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.82 Billion INR | 12.25% |
| 2024 Q1 | 1.44 Billion INR | -15.51% |
| 2023 Q2 | 2.76 Billion INR | 11.94% |
| 2023 Q4 | 1.71 Billion INR | -38.25% |
| 2023 Q3 | 2.77 Billion INR | 0.57% |
| 2023 FY | 6.51 Billion INR | -27.83% |
| 2023 Q1 | 2.46 Billion INR | -1.35% |
| 2022 Q2 | 2.05 Billion INR | -3.02% |
| 2022 Q1 | 2.11 Billion INR | -7.57% |
| 2022 FY | 9.03 Billion INR | 10.01% |
| 2022 Q4 | 2.5 Billion INR | 6.06% |
| 2022 Q3 | 2.35 Billion INR | 14.89% |
| 2021 Q2 | 1.99 Billion INR | -3.31% |
| 2021 Q1 | 2.06 Billion INR | 29.72% |
| 2021 FY | 8.21 Billion INR | 17.05% |
| 2021 Q3 | 1.85 Billion INR | -6.84% |
| 2021 Q4 | 2.29 Billion INR | 23.2% |
| 2020 FY | 7.01 Billion INR | 0.7% |
| 2020 Q2 | 1.9 Billion INR | 22.5% |
| 2020 Q1 | 1.55 Billion INR | -11.1% |
| 2020 Q4 | 1.59 Billion INR | -18.8% |
| 2020 Q3 | 1.96 Billion INR | 2.79% |
| 2019 Q2 | 1.82 Billion INR | 16.58% |
| 2019 FY | 6.96 Billion INR | 10.78% |
| 2019 Q4 | 1.75 Billion INR | -4.51% |
| 2019 Q3 | 1.83 Billion INR | 0.73% |
| 2019 Q1 | 1.56 Billion INR | -6.53% |
| 2018 FY | 6.28 Billion INR | 4.43% |
| 2018 Q2 | 1.62 Billion INR | 10.47% |
| 2018 Q1 | 1.46 Billion INR | 0.0% |
| 2018 Q3 | 1.52 Billion INR | -5.74% |
| 2018 Q4 | 1.67 Billion INR | 9.29% |
| 2017 FY | 6.02 Billion INR | -2.13% |
| 2016 FY | 6.15 Billion INR | 18.66% |
| 2015 FY | 5.18 Billion INR | 18.64% |
| 2014 Q1 | 983.4 Million INR | 0.0% |
| 2014 FY | 4.37 Billion INR | 18.08% |
| 2013 FY | 3.7 Billion INR | 23.92% |
| 2013 Q1 | 770.7 Million INR | 19.68% |
| 2012 Q3 | 728.4 Million INR | 0.0% |
| 2012 FY | 2.98 Billion INR | 39.08% |
| 2012 Q4 | 643.97 Million INR | -11.59% |
| 2011 FY | 2.14 Billion INR | 4.08% |
| 2010 FY | 2.06 Billion INR | -36.9% |
| 2009 FY | 3.27 Billion INR | 58.28% |
| 2008 FY | 2.06 Billion INR | 0.0% |
| 2007 FY | - INR | -100.0% |
| 2006 FY | 2.53 Billion INR | 34.39% |
| 2005 FY | 1.88 Billion INR | 26.07% |
| 2004 FY | 1.49 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -1979.923% |
| Ind-Swift Limited | 946.56 Million INR | -1174.205% |
| Bajaj HealthCare Limited | 985.34 Million INR | -1124.059% |
| Sakar Healthcare Limited | 204.07 Million INR | -5810.067% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 78.33% |
| Innova Captab Limited | 931.03 Million INR | -1195.469% |
| Divi's Laboratories Limited | 14.17 Billion INR | 14.882% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -387.617% |
| Morepen Laboratories Limited | 1.98 Billion INR | -506.868% |
| Mankind Pharma Limited | 29.27 Billion INR | 58.797% |
| Sequent Scientific Limited | 2.9 Billion INR | -315.644% |
| Wanbury Limited | 978.96 Million INR | -1132.035% |
| Laurus Labs Limited | 11.9 Billion INR | -1.271% |
| Nectar Lifesciences Limited | 932.7 Million INR | -1193.149% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -3.612% |
| Alembic Limited | 872.45 Million INR | -1282.44% |
| Hikal Limited | 4.46 Billion INR | -170.2% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 23.999% |
| Neuland Laboratories Limited | 2.92 Billion INR | -311.681% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 18.464% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 74.312% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -447.988% |
| Themis Medicare Limited | 1.12 Billion INR | -971.347% |
| RPG Life Sciences Limited | 1.63 Billion INR | -637.463% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 90.367% |
| Lupin Limited | 125.09 Billion INR | 90.358% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -475.979% |
| Wockhardt Limited | 8.48 Billion INR | -42.231% |
| Vaishali Pharma Limited | 84.02 Million INR | -14253.622% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -292.311% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -2650.246% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 16.555% |
| FDC Limited | 3.49 Billion INR | -244.63% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 87.42% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -2824.446% |
| Eris Lifesciences Limited | 4.94 Billion INR | -144.009% |
| Venus Remedies Limited | 1.91 Billion INR | -529.406% |
| ZIM Laboratories Limited | 1.01 Billion INR | -1090.574% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -749.846% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -20592.426% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -454.666% |
| Shilpa Medicare Limited | 3.33 Billion INR | -261.745% |
| Albert David Limited | 1.02 Billion INR | -1075.388% |
| Ajanta Pharma Limited | 30.46 Billion INR | 60.407% |
| Hester Biosciences Limited | 908.84 Million INR | -1227.099% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -759.802% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -372.229% |
| Gufic Biosciences Limited | 1.18 Billion INR | -916.46% |
| Windlas Biotech Limited | 1 Billion INR | -1098.319% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -302.658% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -84760.374% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -7334.725% |
| Granules India Limited | 10.31 Billion INR | -16.954% |
| Aarti Drugs Limited | 1.16 Billion INR | -933.098% |
| Bal Pharma Limited | 555.62 Million INR | -2070.742% |
| Alkem Laboratories Limited | 32.83 Billion INR | 63.267% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 92.177% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -1022.823% |
| Medicamen Biotech Limited | 335.16 Million INR | -3498.566% |
| Unichem Laboratories Limited | 6.72 Billion INR | -79.326% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -2547.41% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -176750.513% |
| Valiant Laboratories Limited | 138.02 Million INR | -8638.167% |
| Orchid Pharma Limited | 800.77 Million INR | -1406.199% |
| Medico Remedies Limited | 59.67 Million INR | -20111.487% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -467.804% |
| Ipca Laboratories Limited | 18.98 Billion INR | 36.479% |
| Brooks Laboratories Limited | 51.18 Million INR | -23466.247% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -3389.599% |
| Piramal Enterprises Limited | 63.65 Billion INR | 81.052% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 43.697% |
| NATCO Pharma Limited | 10.05 Billion INR | -19.917% |
| Suven Life Sciences Limited | 109.75 Million INR | -10889.708% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -26031.391% |
| Strides Pharma Science Limited | 9.16 Billion INR | -31.639% |
| Alpa Laboratories Limited | 127.38 Million INR | -9368.68% |
| Lasa Supergenerics Limited | 291.17 Million INR | -4042.267% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -292.005% |